ReviewFrontiers in pain research (Lausanne, Switzerland)2025
The potential application of electrophysiological indicators in TMS treatment for MOH.
Review in Frontiers in pain research (Lausanne, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication Overuse Headache (MOH) can lead to central sensitization (CS), habituation deficits (HD), shortened cortical silent period duration (CSPD), and increased pre-activation levels (PAL), all of which are quantifiable electrophysiological objective indicators related to MOH. Transcranial magnetic stimulation (TMS) is a treatment method for MOH and is primarily divided into three types: single-pulse TMS (sTMS), repetitive TMS (rTMS), and quadruple-pulse TMS (qTMS). Among these, sTMS is convenient for patients of self-administration, qTMS significantly improves the effectiveness of TMS treatment, and rTMS is suitable for widespread use in developing countries. Numerous studies have reported clinical symptom improvements in MOH patients treated with TMS, with statistically significant results. However, only a few studies have observed electrophysiological changes in MOH patients before and after treatment. Whether quantifiable objective indicators can be reversed requires further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.